Tipiracil

Basic Information

Item Value
DrugBank ID DB09343
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 cecum villous adenoma KG + DL
2 lipoma of colon KG + DL
3 rectosigmoid junction neoplasm KG + DL
4 cecum neuroendocrine tumor G1 KG + DL
5 colonic lymphangioma KG + DL
6 cecal disease KG + DL
7 colon leiomyoma KG + DL
8 benign neoplasm of cecum KG + DL
9 cavernous hemangioma of colon KG + DL
10 colorectal gastrointestinal stromal tumor KG + DL
11 colorectal hamartoma KG + DL
12 colorectal leiomyoma KG + DL
13 rectosigmoid carcinoma KG + DL
14 colon carcinoma in situ KG + DL
15 colon small cell neuroendocrine carcinoma KG + DL
16 Rotor syndrome KG + DL
17 sigmoid neoplasm KG + DL
18 colorectal lymphoma KG + DL
19 cecum lymphoma KG + DL
20 appendix cancer KG + DL
21 metabolic myopathy due to lactate transporter defect KG + DL
22 metastatic malignant neoplasm KG + DL
23 colon mucosa-associated lymphoid tissue lymphoma KG + DL
24 ketoacidosis due to monocarboxylate transporter-1 deficiency KG + DL
25 measles KG + DL
26 rectosigmoid junction cancer KG + DL
27 gastric carcinoma KG + DL
28 rectum lymphoma KG + DL
29 colorectal adenoma KG + DL
30 carcinoma in situ of gastric cardia KG + DL
31 Epstein-Barr virus-associated carcinoma KG + DL
32 carcinoma in situ of gastric body KG + DL
33 X-linked diffuse leiomyomatosis-Alport syndrome KG + DL
34 isolated Dandy-Walker malformation KG + DL
35 malignant gastric germ cell tumor KG + DL
36 malignant gastric granular cell tumor KG + DL
37 cardia cancer KG + DL
38 gastric lymphoma KG + DL
39 pylorus cancer KG + DL
40 myoglobinuria, acute recurrent, autosomal recessive KG + DL
41 cephalocele (disease) KG + DL
42 gingival fibromatosis-hypertrichosis syndrome KG + DL
43 atypical hemolytic-uremic syndrome with MCP/CD46 anomaly KG + DL
44 autosomal recessive cutis laxa type 2, classic type KG + DL
45 hypertrophic osteoarthropathy, primary KG + DL
46 myopathy due to myoadenylate deaminase deficiency KG + DL
47 Pyle disease KG + DL
48 neurodegeneration, childhood-onset, with cerebellar atrophy KG + DL
49 ectodermal dysplasia, hypohidrotic/hair/nail/tooth type KG + DL
50 acrocephalopolydactyly KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.